THC - Tenet Healthcare - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US88033G4073

Hospitals, Surgery, Imaging, Pharmacies, Laboratories, Therapy

Tenet Healthcare Corporation is a leading healthcare services company in the United States, operating a diverse range of healthcare facilities and services across the country. The company's operations are divided into two main segments: Hospital Operations and Services, and Ambulatory Care.

Through its Hospital Operations and Services segment, Tenet Healthcare Corporation operates a network of general hospitals that provide a comprehensive range of acute care services. These services include operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. Additionally, the company's hospitals offer specialized services such as intensive and critical care, coronary care units, and cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services.

Furthermore, Tenet Healthcare Corporation's hospitals provide advanced tertiary care services, including cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services. The company also offers quaternary care services, which include heart and kidney transplants, as well as limb salvaging vascular procedures, acute level 1 trauma, intravascular stroke care, and minimally invasive cardiac valve replacement services.

In addition to its hospital services, Tenet Healthcare Corporation operates a range of outpatient services, including physical therapy, imaging, surgical robotic, and telemedicine access services. The company's ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals provide patients with convenient access to high-quality healthcare services.

Tenet Healthcare Corporation's services also include a range of procedures and specialties, such as orthopedics, total joint replacement, spinal and other musculoskeletal procedures, gastroenterology, pain management, otolaryngology, ophthalmology, and urology. With a strong commitment to delivering high-quality patient care, Tenet Healthcare Corporation has established itself as a trusted healthcare provider in the United States.

Founded in 1967, Tenet Healthcare Corporation is headquartered in Dallas, Texas, and operates a large network of healthcare facilities across the country. For more information, please visit the company's website at https://www.tenethealth.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for THC - Tenet Healthcare  - Stock Price & Dividends

THC Stock Overview

Market Cap in USD 15,702m
Sector Healthcare
Industry Medical Care Facilities
GiC SubIndustry Health Care Facilities
TER 0.00%
IPO / Inception 1982-01-04

THC Stock Ratings

Growth 5y 91.6
Fundamental 21.9
Dividend 0.00
Rel. Performance vs Sector 8.83
Analysts 4.55/5
Fair Price Momentum 241.27 USD
Fair Price DCF 489.71 USD

THC Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.2%

THC Growth Ratios

Growth 12m 192.21%
Growth Correlation 12m 98.2%
Growth Correlation 3m 53.8%
CAGR 5y 44.97%
CAGR/Mean DD 5y 2.36
Sharpe Ratio 12m 5.44
Alpha vs SP500 12m 135.22
Beta vs SP500 5y weekly 1.45
ValueRay RSI 33.89
Volatility GJR Garch 1y 34.15%
Price / SMA 50 -0.07%
Price / SMA 200 28.35%
Current Volume 631.2k
Average Volume 20d 959.4k

External Links for THC Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of THC stocks?
As of October 22, 2024, the stock is trading at USD 159.72 with a total of 631,183 shares traded.
Over the past week, the price has changed by +2.85%, over one month by -3.29%, over three months by +18.40% and over the past year by +184.96%.
What are the forecast for THC stock price target?
According to ValueRays Forecast Model, THC Tenet Healthcare will be worth about 262.7 in October 2025. The stock is currently trading at 159.72. This means that the stock has a potential upside of +64.44%.
Issuer Forecast Upside
Wallstreet Target Price 170.1 6.52
Analysts Target Price 0.2 -99.9
ValueRay Target Price 262.7 64.4